US5380738A
(en)
*
|
1993-05-21 |
1995-01-10 |
Monsanto Company |
2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
|
US6090834A
(en)
*
|
1993-05-21 |
2000-07-18 |
G.D. Searle & Co. |
Substituted oxazoles for the treatment of inflammation
|
US5616601A
(en)
*
|
1994-07-28 |
1997-04-01 |
Gd Searle & Co |
1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
|
US6613789B2
(en)
|
1994-07-28 |
2003-09-02 |
G. D. Searle & Co. |
Heterocyclo-substituted imidazoles for the treatment of inflammation
|
JP2636819B2
(ja)
|
1994-12-20 |
1997-07-30 |
日本たばこ産業株式会社 |
オキサゾール系複素環式芳香族化合物
|
JP3181190B2
(ja)
*
|
1994-12-20 |
2001-07-03 |
日本たばこ産業株式会社 |
オキサゾール誘導体
|
AU5860396A
(en)
|
1995-05-19 |
1996-11-29 |
G.D. Searle & Co. |
Substituted oxazoles for the treatment of inflammation
|
US5643933A
(en)
*
|
1995-06-02 |
1997-07-01 |
G. D. Searle & Co. |
Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
US6515014B2
(en)
|
1995-06-02 |
2003-02-04 |
G. D. Searle & Co. |
Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
US6512121B2
(en)
|
1998-09-14 |
2003-01-28 |
G.D. Searle & Co. |
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
WO1996038418A1
(en)
*
|
1995-06-02 |
1996-12-05 |
G.D. Searle & Co. |
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
US5700816A
(en)
*
|
1995-06-12 |
1997-12-23 |
Isakson; Peter C. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
|
EP0833664A1
(de)
*
|
1995-06-12 |
1998-04-08 |
G.D. SEARLE & CO. |
Kombination aus einem cyclooxygenase-2 inhibitor und einem leukotrien b4 rezeptorantagonisten zur behandlung von entzündungen
|
US6136839A
(en)
*
|
1995-06-12 |
2000-10-24 |
G. D. Searle & Co. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
|
US6593361B2
(en)
|
1995-07-19 |
2003-07-15 |
Merck & Co Inc |
Method of treating colonic adenomas
|
US5968974A
(en)
|
1995-07-19 |
1999-10-19 |
Merck & Co., Inc. |
Method of treating colonic adenomas
|
AU7095096A
(en)
*
|
1995-09-29 |
1997-04-28 |
Shionogi & Co., Ltd. |
Alpha-substituted benzyl heterocyclic derivatives, intermediates for producing the same, and pesticides containing the same as active ingredient
|
KR19990064310A
(ko)
*
|
1995-10-17 |
1999-07-26 |
윌리암스 로저 에이 |
시클로옥시게나제-2의 검출방법
|
ES2183140T3
(es)
|
1996-02-13 |
2003-03-16 |
Searle & Co |
Combinaciones, que tienen efectos inmunosupresores, que contienen un inhibidor de ciclooxigenasa-2 y un inhibidor de leucotrieno a4 hidrolasa.
|
PT888127E
(pt)
|
1996-02-13 |
2002-05-31 |
Searle & Co |
Combinacoes tendo efeitos imunossupresores contendo inibidores de cilcooxigenase-2 e inibidores de 5-lipoxigenase
|
WO1997029775A1
(en)
*
|
1996-02-13 |
1997-08-21 |
G.D. Searle & Co. |
Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
|
ES2125161B1
(es)
*
|
1996-03-21 |
1999-11-16 |
Grupo Farmaceutico Almirall S |
Nuevos derivados de 2-(3h)-oxazolona.
|
US5908858A
(en)
*
|
1996-04-05 |
1999-06-01 |
Sankyo Company, Limited |
1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
|
CN1098256C
(zh)
*
|
1996-04-12 |
2003-01-08 |
G·D·瑟尔公司 |
作为cox-2抑制剂前药的取代的苯磺酰胺衍生物
|
US6677364B2
(en)
*
|
1998-04-20 |
2004-01-13 |
G.D. Searle & Co. |
Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
|
US5750726A
(en)
*
|
1996-06-28 |
1998-05-12 |
American Cyanamid Company |
Process for the manufacture of 2-aryl-5-perfluoroalkylpyrrole derivatives and intermediates useful therefor
|
US5777132A
(en)
*
|
1996-06-28 |
1998-07-07 |
American Cyanamid Company |
Process for the manufacture of 2-aryl-5 perfluoroalkylpyrrole derivatives
|
US5945538A
(en)
*
|
1996-06-28 |
1999-08-31 |
American Cyanamid Company |
Ammonium oxazole and amino oxazolium intermediates, methods for the preparation thereof and the use therefor in the manufacture of insecticidal arylpyrroles
|
US5925773A
(en)
*
|
1996-06-28 |
1999-07-20 |
American Cyanamid Company |
Ammonium oxazole and amino oxazolium intermediates, methods for the preparation thereof and the use thereof in the manufacture of insecticidal arylpyrroles
|
FR2753449B1
(fr)
*
|
1996-09-13 |
1998-12-04 |
Union Pharma Scient Appl |
Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
|
CA2267186C
(en)
|
1996-10-15 |
2002-05-14 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
AU745797B2
(en)
*
|
1997-04-18 |
2002-03-28 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
|
ES2131015B1
(es)
*
|
1997-09-12 |
2000-03-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de 2-(3h)-oxazolona, procedimientos para su preparacion y su empleo en composiciones farmaceuticas.
|
US6025353A
(en)
*
|
1997-11-19 |
2000-02-15 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
|
NZ333399A
(en)
*
|
1997-12-24 |
2000-05-26 |
Sankyo Co |
Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
|
IT1303672B1
(it)
|
1998-07-28 |
2001-02-23 |
Nicox Sa |
Sali nitrati di farmaci attivi nei disordini ossei
|
US6649645B1
(en)
|
1998-12-23 |
2003-11-18 |
Pharmacia Corporation |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US20030013739A1
(en)
*
|
1998-12-23 |
2003-01-16 |
Pharmacia Corporation |
Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US20010024664A1
(en)
*
|
1999-03-19 |
2001-09-27 |
Obukowicz Mark G. |
Selective COX-2 inhibition from edible plant extracts
|
FR2800373B1
(fr)
*
|
1999-10-27 |
2001-12-07 |
Oreal |
Procede de preparation d'oxazoles trisubstitues
|
IL144760A0
(en)
*
|
1999-12-08 |
2002-06-30 |
Pharmacia Corp |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
|
RU2002119574A
(ru)
|
1999-12-23 |
2004-01-10 |
Нитромед, Инк. (Us) |
Нитрозированные и нитрозилированные ингибиторы циклооксигеназы-2, композиции на их основе и способы их применения
|
DE10001166A1
(de)
|
2000-01-13 |
2001-07-19 |
Merckle Gmbh |
Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
|
WO2001081333A2
(en)
*
|
2000-04-25 |
2001-11-01 |
Pharmacia Corporation |
Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
AU5754701A
(en)
*
|
2000-07-13 |
2002-01-30 |
Pharmacia Corp |
Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
|
ATE366569T1
(de)
*
|
2000-07-20 |
2007-08-15 |
Lauras As |
Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
WO2002017896A2
(en)
*
|
2000-08-29 |
2002-03-07 |
Peter Van Patten |
Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
|
WO2002047706A2
(en)
*
|
2000-12-15 |
2002-06-20 |
Pharmacia Corporation |
Selective cox-2 inhibition from plant extracts
|
JP2004517838A
(ja)
*
|
2000-12-15 |
2004-06-17 |
ファルマシア・コーポレーション |
非食用植物抽出物による選択的cox−2阻害
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
WO2002062391A2
(en)
*
|
2001-02-02 |
2002-08-15 |
Pharmacia Corporation |
Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea
|
US7695736B2
(en)
|
2001-04-03 |
2010-04-13 |
Pfizer Inc. |
Reconstitutable parenteral composition
|
US20030105144A1
(en)
|
2001-04-17 |
2003-06-05 |
Ping Gao |
Stabilized oral pharmaceutical composition
|
US6673818B2
(en)
|
2001-04-20 |
2004-01-06 |
Pharmacia Corporation |
Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
|
US20030153801A1
(en)
*
|
2001-05-29 |
2003-08-14 |
Pharmacia Corporation |
Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
|
EP1554572B1
(de)
|
2001-07-25 |
2009-10-14 |
Raptor Pharmaceutical Inc. |
Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
|
UA80682C2
(en)
*
|
2001-08-06 |
2007-10-25 |
Pharmacia Corp |
Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
|
AR038957A1
(es)
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
Terapia de combinacion para el tratamiento del cancer
|
US20030236308A1
(en)
*
|
2001-09-18 |
2003-12-25 |
Pharmacia Corporation |
Compositions of cyclooxygenase-2 selective inhibitors and acetaminophen for treatment and prevention of inflammation, inflammation-mediated disorders and pain
|
US20030114483A1
(en)
*
|
2001-09-18 |
2003-06-19 |
Pharmacia Corporation |
Compositions of chromene cyclooxygenase-2 selective inhibitors and acetaminophen for treatment and prevention of inflammation, inflammation-mediated disorders and pain
|
US20050107404A1
(en)
|
2001-12-06 |
2005-05-19 |
Fraley Mark E. |
Mitotic kinesin inhibitors
|
US20040062823A1
(en)
*
|
2001-12-13 |
2004-04-01 |
Obukowicz Mark G. |
Selective cox-2 inhibition from non-edible plant extracts
|
US20040126438A1
(en)
*
|
2001-12-13 |
2004-07-01 |
Obukowicz Mark G. |
Selective cox-2 inhibition from plant extracts
|
TW562937B
(en)
*
|
2002-03-26 |
2003-11-21 |
Nanya Technology Corp |
Method for fast determining defect type of word line
|
US7329401B2
(en)
*
|
2002-04-15 |
2008-02-12 |
The Regents Of The University Of California |
Cyclooxygenase-2 selective agents useful as imaging probes and related methods
|
WO2003089427A1
(en)
*
|
2002-04-22 |
2003-10-30 |
Pfizer Products Inc. |
Indol-2-ones as selective inhibitors of cyclooxygenase-2
|
WO2003095623A2
(en)
*
|
2002-05-10 |
2003-11-20 |
The Trustees Of Columbia University In The City Of New York |
Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
|
US20030225054A1
(en)
*
|
2002-06-03 |
2003-12-04 |
Jingwu Duan |
Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents
|
US7087630B2
(en)
*
|
2002-06-27 |
2006-08-08 |
Nitromed, Inc. |
Cyclooxygenase 2 selective inhibitors, compositions and methods of use
|
CA2492066A1
(en)
|
2002-06-28 |
2004-01-08 |
Nitromed, Inc. |
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
BR0312402A
(pt)
*
|
2002-07-02 |
2005-04-26 |
Pharmacia Corp |
Utilização de inibidores seletivos de ciclooxigenase-2 e agentes trombolìticos para o tratamento ou prevenção de um episódio vaso-oclusivo
|
PT1572173E
(pt)
|
2002-12-13 |
2010-05-10 |
Warner Lambert Co |
Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior
|
PL377427A1
(pl)
*
|
2002-12-19 |
2006-02-06 |
Pharmacia Corporation |
Sposoby i kompozycje do leczenia infekcji wirusem opryszczki z zastosowaniem inhibitorów selektywnych względem cyklooksygenazy-2 lub inhibitorów cyklooksygenazy-2 w połączeniu ze środkami przeciwwirusowymi
|
US20040171664A1
(en)
*
|
2002-12-20 |
2004-09-02 |
Pharmacia Corporation |
Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event
|
TW200505446A
(en)
*
|
2003-01-17 |
2005-02-16 |
Fuj Isawa Pharmaceutical Co Ltd |
Inhibitor of cox
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20050026902A1
(en)
*
|
2003-01-31 |
2005-02-03 |
Timothy Maziasz |
Methods and compositions for the treatment or prevention of human immunodeficiency virus and related conditions using cyclooxygenase-2 selective inhibitors and antiviral agents
|
DE602004002832T2
(de)
*
|
2003-05-07 |
2007-06-06 |
Osteologix A/S |
Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
|
ES2394782T3
(es)
*
|
2003-05-07 |
2013-02-05 |
Osteologix A/S |
Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos
|
EP1643995A1
(de)
*
|
2003-06-24 |
2006-04-12 |
Pharmacia Corporation |
Behandlung von migräne mit begleitender übelkeit
|
CA2536173A1
(en)
*
|
2003-08-20 |
2005-03-03 |
Nitromed, Inc. |
Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
|
JP2007504136A
(ja)
*
|
2003-08-28 |
2007-03-01 |
ニトロメッド インコーポレーティッド |
ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法
|
US7070816B2
(en)
*
|
2003-12-05 |
2006-07-04 |
New Chapter, Inc. |
Methods for treating prostatic intraepithelial neoplasia with herbal compositions
|
US7067159B2
(en)
*
|
2003-12-05 |
2006-06-27 |
New Chapter, Inc. |
Methods for treating prostate cancer with herbal compositions
|
US7449462B2
(en)
|
2004-01-22 |
2008-11-11 |
Pfizer, Inc. |
Triazole derivatives which inhibit vasopressin antagonistic activity
|
CA2554716A1
(en)
*
|
2004-01-22 |
2005-08-04 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated compounds, compositions and methods of use
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
AU2005247943A1
(en)
|
2004-05-23 |
2005-12-08 |
Gerard M. Housey |
Theramutein modulators
|
PE20060362A1
(es)
*
|
2004-05-24 |
2006-05-15 |
Irm Llc |
Compuestos de oxazol como moduladores de ppar
|
DE602005023730D1
(de)
|
2004-07-01 |
2010-11-04 |
Merck Sharp & Dohme |
Inhibitoren von mitotischem kinesin
|
US7622142B2
(en)
*
|
2004-09-14 |
2009-11-24 |
New Chapter Inc. |
Methods for treating glioblastoma with herbal compositions
|
US8067464B2
(en)
|
2004-10-04 |
2011-11-29 |
Nitromed, Inc. |
Compositions and methods using apocynin compounds and nitric oxide donors
|
CA2576279A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
|
AU2005306629A1
(en)
*
|
2004-11-15 |
2006-05-26 |
Nicox S.A. |
Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use
|
JP2008528507A
(ja)
*
|
2005-01-21 |
2008-07-31 |
ニトロメッド インコーポレーティッド |
複素環式の酸化窒素供与体基を含む心血管化合物、組成物および使用方法
|
CA2597422A1
(en)
*
|
2005-02-16 |
2007-08-02 |
Nitromed, Inc. |
Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
|
US7521435B2
(en)
*
|
2005-02-18 |
2009-04-21 |
Pharma Diagnostics, N.V. |
Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
|
JP2008531697A
(ja)
*
|
2005-02-28 |
2008-08-14 |
ニトロメッド インコーポレーティッド |
酸化窒素増強基を含む心血管化合物、組成物および使用法
|
AU2006223392A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Nicox S.A. |
Organic nitric oxide enhancing salts of angiotensin II antagonists, compositions and methods of use
|
AU2006228869A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Astion Pharma A/S |
Oxaprozin or a closely related compound for the treatment of eczema
|
AR054336A1
(es)
*
|
2005-03-30 |
2007-06-20 |
Astion Dev As |
Tratamiento de enfermedades dermatologicas y del prurito
|
CN103259027A
(zh)
|
2005-04-28 |
2013-08-21 |
普罗透斯数字保健公司 |
药物信息系统
|
ATE550019T1
(de)
|
2005-05-17 |
2012-04-15 |
Merck Sharp & Dohme |
Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
|
WO2006127591A2
(en)
*
|
2005-05-23 |
2006-11-30 |
Nitromed, Inc. |
Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use
|
US8431110B2
(en)
|
2005-05-23 |
2013-04-30 |
Hmi Medical Innovations, Llc. |
Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
|
US20090018091A1
(en)
*
|
2005-08-02 |
2009-01-15 |
Nitromed, Inc. |
Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use
|
PE20070427A1
(es)
*
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
|
CA2624933A1
(en)
*
|
2005-10-04 |
2007-04-12 |
Nitromed, Inc. |
Methods for treating respiratory disorders
|
US7838023B2
(en)
*
|
2005-11-16 |
2010-11-23 |
Nitromed, Inc. |
Furoxan compounds, compositions and methods of use
|
CN103789389B
(zh)
*
|
2005-11-23 |
2017-01-04 |
杰勒德·M·豪斯 |
鉴定、合成、优化和表征蛋白调节剂的化合物和方法
|
EP1968584A2
(de)
*
|
2005-12-20 |
2008-09-17 |
Nitromed, Inc. |
Stickoxid-verstärkende glutaminsäure-verbindungen, zusammensetzungen und anwendungsverfahren
|
WO2007075542A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Nitromed, Inc. |
Nitric oxide enhancing pyruvate compounds, compositions and methods of use
|
US20090062302A1
(en)
|
2006-01-24 |
2009-03-05 |
Buser-Doepner Carolyn A |
Jak2 Tyrosine Kinase Inhibition
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
AU2007243765A1
(en)
|
2006-03-29 |
2007-11-08 |
Nicox S.A. |
Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
|
KR101464385B1
(ko)
|
2006-04-19 |
2014-11-21 |
노파르티스 아게 |
6-o-치환된 벤즈옥사졸 및 벤조티아졸 화합물, 및 csf-1r 신호전달의 억제 방법
|
WO2008033466A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions and methods for treatment of viral diseases
|
CA2663377A1
(en)
|
2006-09-18 |
2008-03-27 |
Raptor Pharmaceutical Inc. |
Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
|
CA2664113C
(en)
|
2006-09-22 |
2013-05-28 |
Merck & Co., Inc. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
WO2008052198A2
(en)
*
|
2006-10-26 |
2008-05-02 |
Reliant Technologies, Inc. |
Methods of increasing skin permeability by treatment with electromagnetic radiation
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
CA2673545A1
(en)
|
2006-12-22 |
2008-07-03 |
Recordati Ireland Limited |
Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
|
DK2805945T3
(da)
|
2007-01-10 |
2019-07-15 |
Msd Italia Srl |
Amid-substituerede indazoler som poly(adp-ribose)polymerase- (parp) hæmmere
|
EP2114461A2
(de)
*
|
2007-01-19 |
2009-11-11 |
Mallinckrodt Inc. |
Diagnostische und therapeutische cyclooxygenase-2-bindende liganden
|
MX2009009304A
(es)
|
2007-03-01 |
2009-11-18 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso.
|
WO2008144062A1
(en)
|
2007-05-21 |
2008-11-27 |
Novartis Ag |
Csf-1r inhibitors, compositions, and methods of use
|
EP2170076B1
(de)
|
2007-06-27 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino-derivate als histondeacetylase-hemmer
|
US20090011060A1
(en)
*
|
2007-07-06 |
2009-01-08 |
Peter Koepke |
Campsiandra angustifolia extract and methods of extracting and using such extract
|
US20090017140A1
(en)
*
|
2007-07-09 |
2009-01-15 |
Peter Koepke |
Maytenus abenfolia extract and methods of extracting and using such extract
|
EA201000016A1
(ru)
|
2007-07-12 |
2010-10-29 |
Трагара Фармасьютикалс, Инк. |
Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
|
US20090035395A1
(en)
*
|
2007-08-01 |
2009-02-05 |
Peter Koepke |
Spondias mombin l. extract and methods of extracting and using such extract
|
CA2699157A1
(en)
|
2007-09-10 |
2009-03-19 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US7879369B2
(en)
*
|
2007-09-18 |
2011-02-01 |
Selvamedica, Llc |
Combretum laurifolium Mart. extract and methods of extracting and using such extract
|
CA2717509A1
(en)
|
2008-03-03 |
2009-09-11 |
Tiger Pharmatech |
Tyrosine kinase inhibitors
|
RU2472791C2
(ru)
|
2008-08-27 |
2013-01-20 |
КалсиМедика Инк. |
Соединения, модулирующие внутриклеточный кальций
|
EP2398500B1
(de)
|
2009-02-20 |
2019-03-13 |
2-BBB Medicines B.V. |
Arzneiabgabesystem auf glutathion-basis
|
CA2760945A1
(en)
|
2009-05-06 |
2010-11-11 |
Laboratory Skin Care, Inc. |
Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
|
UA109417C2
(uk)
|
2009-10-14 |
2015-08-25 |
Мерк Шарп Енд Доме Корп. |
ЗАМІЩЕНІ ПІПЕРИДИНИ, ЯКІ ПІДВИЩУЮТЬ АКТИВНІСТЬ p53, І ЇХ ЗАСТОСУВАННЯ
|
CA2797663C
(en)
|
2010-04-27 |
2018-10-09 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
WO2011139765A2
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
CN103038229B
(zh)
|
2010-05-26 |
2016-05-11 |
桑诺维恩药品公司 |
杂芳基化合物及其使用方法
|
EP2584903B1
(de)
|
2010-06-24 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Neue heterozyklische verbindungen als erk-hemmer
|
EP3330377A1
(de)
|
2010-08-02 |
2018-06-06 |
Sirna Therapeutics, Inc. |
Durch rna-interferenz vermittelte hemmung der catenin (cadherin-assoziiertes protein)-beta-1 (ctnnb1)- genexpression mittels kurzer interferierender nukleinsäuren (sina)
|
KR102072631B1
(ko)
|
2010-08-17 |
2020-02-03 |
시르나 쎄러퓨틱스 인코퍼레이티드 |
짧은 간섭 핵산 (siNA)을 사용한 B형 간염 바이러스 (HBV) 유전자 발현의 RNA 간섭 매개 억제
|
EP2608669B1
(de)
|
2010-08-23 |
2016-06-22 |
Merck Sharp & Dohme Corp. |
Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer
|
CN106905311A
(zh)
|
2010-08-27 |
2017-06-30 |
钙医学公司 |
调节细胞内钙的化合物
|
EP2613782B1
(de)
|
2010-09-01 |
2016-11-02 |
Merck Sharp & Dohme Corp. |
Indazolderivate als erk-hemmer
|
US9242981B2
(en)
|
2010-09-16 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Fused pyrazole derivatives as novel ERK inhibitors
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
US9260471B2
(en)
|
2010-10-29 |
2016-02-16 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
|
WO2012087772A1
(en)
|
2010-12-21 |
2012-06-28 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
CN103732592A
(zh)
|
2011-04-21 |
2014-04-16 |
默沙东公司 |
胰岛素样生长因子-1受体抑制剂
|
US9023865B2
(en)
|
2011-10-27 |
2015-05-05 |
Merck Sharp & Dohme Corp. |
Compounds that are ERK inhibitors
|
WO2013066729A1
(en)
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
EP3358013B1
(de)
|
2012-05-02 |
2020-06-24 |
Sirna Therapeutics, Inc. |
Sina-zusammensetzungen
|
US9233979B2
(en)
|
2012-09-28 |
2016-01-12 |
Merck Sharp & Dohme Corp. |
Compounds that are ERK inhibitors
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
CA2892361A1
(en)
|
2012-11-28 |
2014-06-05 |
Merck Sharp & Dohme Corp. |
Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels
|
WO2014100065A1
(en)
|
2012-12-20 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Substituted imidazopyridines as hdm2 inhibitors
|
US9540377B2
(en)
|
2013-01-30 |
2017-01-10 |
Merck Sharp & Dohme Corp. |
2,6,7,8 substituted purines as HDM2 inhibitors
|
EP3019171B1
(de)
|
2013-07-11 |
2018-09-05 |
Merck Sharp & Dohme Corp. |
Substituierte amidopyrazolhemmer von interleukinrezeptor-assoziierten kinasen (irak-4)
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
WO2015054283A1
(en)
|
2013-10-08 |
2015-04-16 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
EP3268003B1
(de)
|
2015-03-12 |
2020-07-29 |
Merck Sharp & Dohme Corp. |
Thienopyrazininhibitoren der irak4-aktivität
|
EP3268367B8
(de)
|
2015-03-12 |
2022-11-16 |
Merck Sharp & Dohme LLC |
Carboxamidinhibitoren der irak4-aktivität
|
WO2016144846A1
(en)
|
2015-03-12 |
2016-09-15 |
Merck Sharp & Dohme Corp. |
Pyrazolopyrimidine inhibitors of irak4 activity
|
WO2016177776A1
(en)
|
2015-05-04 |
2016-11-10 |
Academisch Medisch Centrum |
Biomarkers for the detection of aspirin insensitivity
|
CN104892495B
(zh)
*
|
2015-06-08 |
2017-04-26 |
青岛农业大学 |
一种新的合成含吡啶类化合物的方法
|
EP3706742B1
(de)
|
2017-11-08 |
2023-03-15 |
Merck Sharp & Dohme LLC |
Prmt5-inhibitoren
|
US20210309688A1
(en)
|
2018-08-07 |
2021-10-07 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
EP3833668A4
(de)
|
2018-08-07 |
2022-05-11 |
Merck Sharp & Dohme Corp. |
Prmt5-inhibitoren
|
BR112022012032A2
(pt)
|
2019-12-17 |
2022-09-06 |
Merck Sharp & Dohme Llc |
Inibidores de prmt5
|